OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
Ravinderjit Batta, M. Pharm., is group leader of formulation development at Helix BioPharma.
July 02, 2009
The authors describe a proprietary process for producing a stable, topical interferon alpha-2b formulation that can deliver large drug molecules into the skin or mucosa.